The North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences (NEIGRIHMS) in Shillong has long served as a vital healthcare lifeline for the northeastern region of India. Yet, beyond its clinical mandate of delivering tertiary patient care across rugged terrains and diverse populations, the institute is establishing itself as a powerhouse of clinical and academic research. In a signal achievement that underscores this shift, the Department of Neurology at NEIGRIHMS has brought immense pride to Meghalaya by securing the prestigious Dr. B.C. Roy Gold Medal twice within a five-year window at the Association of Neuroscientists of Eastern India Conference (ANEICON).

The B.C. Roy Gold Medal, named in honour of the legendary physician, educationist, and Bharat Ratna awardee Dr. Bidhan Chandra Roy, represents one of the highest academic distinctions awarded within Eastern India’s neurological community. Bestowed under the aegis of ANEICON, the medal evaluates peer-reviewed original investigations, penalising superficial inquiries and rewarding studies that combine scientific rigour, methodological integrity, and clear clinical utility. Winning this accolade once is a career milestone; capturing it twice in half a decade reflects a sustained, institutional commitment to clinical science.

A Chronicle of Dual Triumphs: From Autoimmunity to Infectious Pathology

The journey began in 2021 when Dr. B. Synmon was awarded the B.C. Roy Gold Medal at the ANEICON annual meeting held in Patna, Bihar. Dr. Synmon’s investigation tackled Myasthenia Gravis, a chronic autoimmune disorder wherein pathogenic antibodies disrupt communication between nerves and muscles, causing debilitating muscle weakness, ocular dysfunction, and potentially fatal respiratory crises.

Managing Myasthenia Gravis demands precise epidemiological insight and individualized treatment strategies, as patient responses to immunosuppressants, plasmapheresis, and thymectomy vary widely. Dr. Synmon’s work shed invaluable light on disease presentation, diagnostic timelines, and outcome patterns in the region. By conducting comprehensive clinical profiling in a patient demographic that has historically been underrepresented in mainstream epidemiological studies, the research yielded critical baseline data that continues to guide neurological treatment protocols throughout Eastern and Northeast India.

Five years later, the department repeated the feat on a national stage. At ANEICON 2026, convened in Ranchi, Jharkhand, from October 9 to 11, Dr. Aakanksha captured the B.C. Roy Gold Medal for cutting-edge investigative work in the field of Neuro-Infections.

Neuro-infections remain one of the most perilous frontiers in clinical neurology, encompassing acute and subacute conditions such as bacterial and tuberculous meningitis, viral encephalitis, fungal invasions of the central nervous system, and parasitic diseases like neurocysticercosis. In resource-variable settings, neuro-infections carry severe risks of permanent cognitive or motor deficits and high mortality if not detected and managed within narrow therapeutic windows. Dr. Aakanksha’s study provided timely, actionable insights into etiology, rapid diagnostic algorithms, and therapeutic outcomes. By addressing the specific microbiological and pathological trends confronting healthcare providers in the Northeast, the paper offered a clear roadmap for mitigating post-infectious morbidity and reducing intensive care mortality.

Leadership, Institutional Culture, and Regional Healthcare

Reacting to the achievement, Prof. Nalin Mehta, Director of NEIGRIHMS, formally congratulated Dr. Synmon, Dr. Aakanksha, and the faculty and staff of the Department of Neurology. Prof. Mehta lauded the clinicians’ dedication, remarking that sustained research output directly translates to enhanced patient outcomes at the bedside.

He noted that conducting high-calibre clinical research in tertiary centres outside Tier-1 metropolitan hubs presents distinct challenges—ranging from infrastructure constraints to complex patient referral logistics. To overcome these hurdles and repeatedly produce award-winning science demonstrates that NEIGRIHMS is cultivating an ecosystem where diagnostic acumen, investigative curiosity, and compassion thrive simultaneously.

The broader healthcare implications for Meghalaya and its neighbouring states are profound. Historically, specialized neurological conditions often compelled patients from the Northeast to undertake arduous, financially draining journeys to major metropolitan hubs like Kolkata, New Delhi, or Vellore. By investing in specialized neuro-intensive care, advanced neurophysiology labs, and comprehensive neuro-imaging, the Department of Neurology at NEIGRIHMS has drastically curtailed this dependence on medical out-migration.

When an institution conducts high-level research on its own patient populations, the resulting clinical guidelines are grounded in local reality. Factors such as endemic pathogens, regional genetic markers in autoimmune illnesses, socio-economic barriers to long-term medication adherence, and geographical delays in emergency triage are factored directly into patient management plans. The accolades won by Dr. Synmon and Dr. Aakanksha are not merely ornamental—they represent therapeutic solutions fine-tuned for the very people the hospital serves.

Strengthening the Research Footprint of the Northeast

The double gold medal triumph at ANEICON also carries wider significance for India’s scientific map:

• Shifting Academic Gravity: Top-tier research accolades have traditionally concentrated within established mainland medical universities. Consecutive victories for a Shillong-based team demonstrate that regional institutes can produce competitive, paradigm-challenging clinical datasets.
• Fostering Mentorship and Resident Training: Academic success breeds further excellence. Exposure to award-winning peer research encourages post-graduate residents and junior doctors at NEIGRIHMS to integrate evidence-based protocols into everyday clinical duties.
• Targeting Unmet Regional Needs: Conditions like refractory neuro-infections and neglected neuromuscular ailments require focused investigations that national studies frequently aggregate or overlook. Regional data collection provides vital intelligence for both state public health policies and hospital procurement strategies.

The Horizon for NEIGRIHMS Neurology

As NEIGRIHMS continues to expand its super-specialty wings, modernise its diagnostic infrastructure, and participate in collaborative multi-centre trials, the Department of Neurology stands out as a beacon of academic diligence. The twin B.C. Roy Gold Medals celebrate two distinct clinical disciplines—the nuanced immunology of neuromuscular junctions explored by Dr. Synmon, and the urgent, high-stakes epidemiology of central nervous system infections tackled by Dr. Aakanksha.

Together, these achievements demonstrate that medical progress in Northeast India is no longer an aspiration waiting to be realized; it is happening in real-time within the wards, intensive care units, and laboratories of Shillong. By converting regional clinical challenges into peer-recognized scientific triumphs, NEIGRIHMS is reshaping the standard of neurological practice and bringing sustained national distinction to Meghalaya.

About The Author

LAJONG11

See author's posts